会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 8. 发明申请
    • F11 RECEPTOR (F11R) ANTAGONISTS AS THERAPEUTIC AGENTS
    • F11受体(F11R)作为治疗药物的拮抗剂
    • US20090202538A1
    • 2009-08-13
    • US12358352
    • 2009-01-23
    • Elizabeth KorneckiAnna BabinskaYigal H. Ehrlich
    • Elizabeth KorneckiAnna BabinskaYigal H. Ehrlich
    • A61K39/395C07K14/00C07K16/18A61K38/16A61P7/04
    • C07K14/70503A61K38/00C07K16/2803C07K2317/76
    • The present invention provides a cell adhesion molecule (CAM), designated F11 receptor (F11R) and its use to inhibit platelet aggregation and platelet adhesion for the treatment and prevention of cardiovascular disorders. Cloned F11R cDNA and full length F11R cDNA and amino acid sequences are provided. F11R-antagonists and methods for the prevention and treatment of thrombosis, atherosclerosis, heart attacks, stroke and other clinical disorders involving thrombus formation are also provided. There are at least two kinds of antagonists that may be employed together. Peptides derived from the extracellular domain of F11R and small molecules and peptidomimetics based on the structure of these peptides, as well as inhibitory antibodies and functional fragments thereof, are shown to inhibit human platelet aggregation and platelet adhesion to endothelial cells, and therefore, inhibit the formation of atherosclerotic plaques.
    • 本发明提供了称为F11受体(F11R)的细胞粘附分子(CAM)及其用于抑制血小板聚集和血小板粘附用于治疗和预防心血管疾病的用途。 提供克隆的F11R cDNA和全长F11R cDNA和氨基酸序列。 还提供了用于预防和治疗血栓形成,动脉粥样硬化,心脏病发作,中风和涉及血栓形成的其他临床病症的F11R-拮抗剂和方法。 至少有两种可以一起使用的拮抗剂。 来自F11R的细胞外结构域的肽和基于这些肽的结构的小分子和肽模拟物以及抑制性抗体及其功能片段显示出抑制人血小板聚集和血小板粘附于内皮细胞,因此抑制 形成动脉粥样硬化斑块。
    • 10. 发明授权
    • Human platelet F11 receptor
    • 人血小板F11受体
    • US06699688B1
    • 2004-03-02
    • US09397243
    • 1999-09-16
    • Elizabeth KorneckiMalgorzata B. Sobocka
    • Elizabeth KorneckiMalgorzata B. Sobocka
    • C07K100
    • G01N33/566C07H21/04C07K14/705G01N2500/00
    • The present invention is directed to isolated nucleic acid molecules encoding human platelet F11 receptors. Expression vectors and host cells comprising the nucleic acid molecules are also provided, as well as methods for increasing or decreasing the expression of the human platelet F11 receptor in host cells. The invention further provides a method of screening a substance for the ability of the substance to modify human platelet F11 receptor function, and a method for isolating other human platelet F11 receptor molecules. DNA oligomers capable of hybridizing to the nucleic acid molecule encoding the human platelet F11 receptor are provided, which can be used to detect human platelet F11 receptor in a sample.
    • 本发明涉及编码人血小板F11受体的分离的核酸分子。 还提供了包含核酸分子的表达载体和宿主细胞,以及用于增加或降低宿主细胞中人血小板F11受体表达的方法。 本发明还提供了筛选物质改变人血小板F11受体功能的能力的方法,以及分离其他人血小板F11受体分子的方法。 提供能够与编码人血小板F11受体的核酸分子杂交的DNA寡聚体,其可用于检测样品中的人血小板F11受体。